Please bring a valid ID, a list of current medications and supplements, recent lab results or medical records, and any specific health goals or concerns
What helps with diarrhea could slow an already sluggish system
Kallyope has announced positive results from its Phase 2b study of the companys lead candidate elismetrep, an oral Transient Receptor Potential Melastatin 8 (TRPM8) antagonist being studied for the acute treatment of migraine
June 23, 2026Download PDF Story at-a-glance GLP-1 drugs such as Ozempic and Wegovy have been linked to serious vision concerns, including diabetic retinopathy and optic nerve damage that can result in lasting vision loss Research suggests the highest risk of sudden vision loss may occur within the first year of starting these drugs, with symptoms sometimes appearing overnight without pain or warning Case reports document that even healthy adults using GLP-1 drugs for weight loss with no history of diabetes or eye disease have experienced lasting vision loss Sudden changes in vision such as blurriness, blind spots, or loss of color perception may be early warning signs of optic nerve damage
It holds LegitScript certification, has a clean disciplinary record, posts clear HIPAA information with a dedicated footer tab, and operates from a verifiable US address in Princeton, NJ
Shelf life: 24 months unopened